Retrieve available abstracts of 1 articles: HTML format
Single Articles
February 2024
SCHONHERR H, Ayaz P, Taylor AM, Casaletto JB, et al Discovery of lirafugratinib (RLY-4008), a highly selective irreversible
small-molecule inhibitor of FGFR2.
Proc Natl Acad Sci U S A. 2024;121:e2317756121. PubMedAbstract available